Evidence map›Paper›PMID 29705833›Full record

ArticleJournal of robotic surgery2018

Robotic-assisted thymectomy for early-stage thymoma: a propensity-score matched analysis.

Monica Casiraghi, Domenico Galetta, Alessandro Borri, Adele Tessitore, Rosalia Romano, Daniela Brambilla, Patrick Maisonneuve, Lorenzo Spaggiari

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. A case of thymic basaloid carcinoma with rectal carcinoma.International journal of surgery case reports · 2020
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Monica CasiraghiDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy. monica.casiraghi@ieo.it.ORCID http://orcid.org/0000-0001-5986-7811
Domenico GalettaDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy.
Alessandro BorriDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy.
Adele TessitoreDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy.
Rosalia RomanoDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy.
Daniela BrambillaDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy.
Patrick MaisonneuveDivision of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
Lorenzo SpaggiariDivision of Thoracic Surgery, European Institute of Oncology, University of Milan, Via G. Ripamonti, 435, 20141, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to analyse the feasibility and safety of robotic-assisted thymectomy (RoT) in patients with clinically early stage thymoma, investigating clinical and early oncological results. Between 1998 and 2017, we retrospectively reviewed 76 (42.2%) patients who underwent radical thymectomy for clinically early stage thymoma (Masaoka-Koga I and II), identifying all patients who underwent RoT (n = 28) or open thymectomy (OT) with eligibility criteria for robotic surgery (n = 48). Using a propensity-score matched for tumor size (3.9 ± 1.8 cm) and stage (35% stage I, 42% stage IIA, 23% stage IIB), we paired 24 patients who had RoT with 24 patients undergoing OT. RoT was left-sided in 19 (79.2%) patients. None of the patients required conversion to open surgery. OT was via sternotomy in 21 (87.5%) patients and thoracotomy in 3 (12.5%). Mean operating time was shorter in the RoT group (117 ± 40 min) than in the OT (141 ± 46 min) (p = 0.06), even if not statistically significant. Length of stay was significantly shorter in the RoT group (mean 4.0 ± 1.9 days) than in the OT (mean 5.9 ± 1.7 days) (p = 0.0009). No significant difference between the two groups regarding post-operative complications. Five patients died in the OT group after a median follow-up of 6.1 years (only one for recurrence). After a median follow-up of 1.3 years, all patients in the RoT group were alive without disease. RoT is feasible and safe for early stage thymoma with clear advantage compared to OT in term of short term outcomes. A longer follow-up is needed to better evaluate the oncological results.

Indexed as

AdultAgedAged, 80 and overFeasibility StudiesFemaleFollow-Up StudiesHumansLength of StayMaleMiddle AgedNeoplasm StagingOperative TimePostoperative ComplicationsPropensity ScoreRetrospective StudiesRobotic Surgical ProceduresRobotic surgeryThymoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.